| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
|
12,720 |
884 |
$516K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
6,756 |
350 |
$27K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
3,162 |
251 |
$3K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,343 |
287 |
$2K |
| 85041 |
|
309 |
263 |
$0.00 |
| 82108 |
|
106 |
97 |
$0.00 |
| 85048 |
|
309 |
264 |
$0.00 |
| 83540 |
|
471 |
384 |
$0.00 |
| 83970 |
|
342 |
253 |
$0.00 |
| A4657 |
Syringe, with or without needle, each |
634 |
494 |
$0.00 |
| 83550 |
|
471 |
384 |
$0.00 |
| 82728 |
|
461 |
375 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
192 |
142 |
$0.00 |
| 90674 |
|
17 |
14 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
18 |
17 |
$0.00 |